Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial

皮质电图 癫痫外科 癫痫 医学 随机对照试验 脑电图 麻醉 外科 精神科
作者
Willemiek Zweiphenning,Maryse A. van ’t Klooster,Nicole van Klink,Frans S.S. Leijten,Cyrille H. Ferrier,Tineke Gebbink,Geertjan Huiskamp,M.J.E. van Zandvoort,Monique M.J. van Schooneveld,M Bourez,Sophie Goemans,Sven Straumann,Peter C. van Rijen,Peter H. Gosselaar,Pieter van Eijsden,Willem M. Otte,Eric van Diessen,Kees P. J. Braun,Maeike Zijlmans,Eltje M. Bloemen-Carlier,Veronika Cibulková,Renee de Munnink,Sandra van der Salm,Martinus J.C. Eijkemans,Janine M. Ophorst-van Eck,Anouk Velders,Charlotte J.J. van Asch,Jack Zwemmer,Renate van Regteren-van Griethuysen,Henriette Smeding,Lydia van der Berg,Jeroen de Bresser,G.A.P. de Kort,Jan-Willem Dankbaar
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:21 (11): 982-993 被引量:60
标识
DOI:10.1016/s1474-4422(22)00311-8
摘要

Intraoperative electrocorticography is used to tailor epilepsy surgery by analysing interictal spikes or spike patterns that can delineate epileptogenic tissue. High-frequency oscillations (HFOs) on intraoperative electrocorticography have been proposed as a new biomarker of epileptogenic tissue, with higher specificity than spikes. We prospectively tested the non-inferiority of HFO-guided tailoring of epilepsy surgery to spike-guided tailoring on seizure freedom at 1 year.The HFO trial was a randomised, single-blind, adaptive non-inferiority trial at an epilepsy surgery centre (UMC Utrecht) in the Netherlands. We recruited children and adults (no age limits) who had been referred for intraoperative electrocorticography-tailored epilepsy surgery. Participants were randomly allocated (1:1) to either HFO-guided or spike-guided tailoring, using an online randomisation scheme with permuted blocks generated by an independent data manager, stratified by epilepsy type. Treatment allocation was masked to participants and clinicians who documented seizure outcome, but not to the study team or neurosurgeon. Ictiform spike patterns were always considered in surgical decision making. The primary endpoint was seizure outcome after 1 year (dichotomised as seizure freedom [defined as Engel 1A-B] vs seizure recurrence [Engel 1C-4]). We predefined a non-inferiority margin of 10% risk difference. Analysis was by intention to treat, with prespecified subgroup analyses by epilepsy type and for confounders. This completed trial is registered with the Dutch Trial Register, Toetsingonline ABR.NL44527.041.13, and ClinicalTrials.gov, NCT02207673.Between Oct 10, 2014, and Jan 31, 2020, 78 individuals were enrolled to the study and randomly assigned (39 to HFO-guided tailoring and 39 to spike-guided tailoring). There was no loss to follow-up. Seizure freedom at 1 year occurred in 26 (67%) of 39 participants in the HFO-guided group and 35 (90%) of 39 in the spike-guided group (risk difference -23·5%, 90% CI -39·1 to -7·9; for the 48 patients with temporal lobe epilepsy, the risk difference was -25·5%, -45·1 to -6·0, and for the 30 patients with extratemporal lobe epilepsy it was -20·3%, -46·0 to 5·4). Pathology associated with poor prognosis was identified as a confounding factor, with an adjusted risk difference of -7·9% (90% CI -20·7 to 4·9; adjusted risk difference -12·5%, -31·0 to 5·9, for temporal lobe epilepsy and 5·8%, -7·7 to 19·5, for extratemporal lobe epilepsy). We recorded eight serious adverse events (five in the HFO-guided group and three in the spike-guided group) requiring hospitalisation. No patients died.HFO-guided tailoring of epilepsy surgery was not non-inferior to spike-guided tailoring on intraoperative electrocorticography. After adjustment for confounders, HFOs show non-inferiority in extratemporal lobe epilepsy. This trial challenges the clinical value of HFOs as an epilepsy biomarker, especially in temporal lobe epilepsy. Further research is needed to establish whether HFO-guided intraoperative electrocorticography holds promise in extratemporal lobe epilepsy.UMCU Alexandre Suerman, EpilepsieNL, RMI Talent Fellowship, European Research Council, and MING Fund.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
浅浅殇完成签到,获得积分10
刚刚
1秒前
3秒前
滴答发布了新的文献求助10
6秒前
高高的天亦完成签到 ,获得积分10
7秒前
星空完成签到 ,获得积分10
8秒前
文艺的青旋完成签到 ,获得积分10
8秒前
青黛完成签到 ,获得积分10
15秒前
大橙子发布了新的文献求助10
19秒前
领导范儿应助科研通管家采纳,获得10
20秒前
量子星尘发布了新的文献求助10
24秒前
明钟达完成签到 ,获得积分10
32秒前
byyyy完成签到,获得积分10
35秒前
高高的哈密瓜完成签到 ,获得积分10
39秒前
Rondab应助橙汁采纳,获得10
42秒前
读书的时候完成签到,获得积分10
44秒前
颜云尔完成签到,获得积分10
55秒前
孤独雨梅完成签到,获得积分10
58秒前
woobinhua完成签到 ,获得积分10
58秒前
雪落你看不见完成签到,获得积分10
1分钟前
十月天秤完成签到,获得积分0
1分钟前
依文完成签到,获得积分20
1分钟前
ymr完成签到 ,获得积分10
1分钟前
哦哦哦完成签到 ,获得积分10
1分钟前
jzmupyj完成签到,获得积分10
1分钟前
大橙子发布了新的文献求助10
1分钟前
xdlongchem完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
小梦完成签到,获得积分10
1分钟前
xuhang完成签到,获得积分10
1分钟前
ZSHAN完成签到,获得积分10
1分钟前
美满的机器猫完成签到,获得积分10
1分钟前
王小磊完成签到,获得积分10
1分钟前
谢花花完成签到 ,获得积分10
1分钟前
1分钟前
瓦罐完成签到 ,获得积分10
1分钟前
扁舟灬完成签到,获得积分10
1分钟前
Cpp完成签到 ,获得积分10
1分钟前
贤惠的老黑完成签到 ,获得积分10
1分钟前
ame1120发布了新的文献求助10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022